These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23449072)

  • 1. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
    Lin Z; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misfolded PrP and a novel mechanism of proteasome inhibition.
    Andre R; Tabrizi SJ
    Prion; 2012; 6(1):32-6. PubMed ID: 22453175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prions and the proteasome.
    Deriziotis P; Tabrizi SJ
    Biochim Biophys Acta; 2008 Dec; 1782(12):713-22. PubMed ID: 18644436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between 20S proteasomes and prion proteins in scrapie disease.
    Amici M; Cecarini V; Cuccioloni M; Angeletti M; Barocci S; Rossi G; Fioretti E; Keller JN; Eleuteri AM
    J Neurosci Res; 2010 Jan; 88(1):191-201. PubMed ID: 19658198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.
    Cronier S; Carimalo J; Schaeffer B; Jaumain E; Béringue V; Miquel MC; Laude H; Peyrin JM
    FASEB J; 2012 Sep; 26(9):3854-61. PubMed ID: 22661006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.
    Kang SC; Brown DR; Whiteman M; Li R; Pan T; Perry G; Wisniewski T; Sy MS; Wong BS
    J Pathol; 2004 May; 203(1):603-8. PubMed ID: 15095484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.
    Deriziotis P; André R; Smith DM; Goold R; Kinghorn KJ; Kristiansen M; Nathan JA; Rosenzweig R; Krutauz D; Glickman MH; Collinge J; Goldberg AL; Tabrizi SJ
    EMBO J; 2011 Jul; 30(15):3065-77. PubMed ID: 21743439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
    McKinnon C; Goold R; Andre R; Devoy A; Ortega Z; Moonga J; Linehan JM; Brandner S; Lucas JJ; Collinge J; Tabrizi SJ
    Acta Neuropathol; 2016 Mar; 131(3):411-25. PubMed ID: 26646779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of proteasomes in prion disease.
    Zhu T; Hayat Khan S; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):531-9. PubMed ID: 24829398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion-Associated Neurodegeneration Causes Both Endoplasmic Reticulum Stress and Proteasome Impairment in a Murine Model of Spontaneous Disease.
    Otero A; Betancor M; Eraña H; Fernández Borges N; Lucas JJ; Badiola JJ; Castilla J; Bolea R
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular prion protein mediates toxic signaling of amyloid beta.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Neurodegener Dis; 2012; 10(1-4):298-300. PubMed ID: 22156337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.
    Apodaca J; Kim I; Rao H
    Biochem Biophys Res Commun; 2006 Aug; 347(1):319-26. PubMed ID: 16808901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.
    Ben-Gedalya T; Lyakhovetsky R; Yedidia Y; Bejerano-Sagie M; Kogan NM; Karpuj MV; Kaganovich D; Cohen E
    J Cell Sci; 2011 Jun; 124(Pt 11):1891-902. PubMed ID: 21558416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion and anti-codon usage: does infectious PrP alter tRNA abundance to induce misfolding of PrP?
    Rechavi O; Kloog Y
    Med Hypotheses; 2009 Feb; 72(2):193-5. PubMed ID: 18809261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.
    Kristiansen M; Messenger MJ; Klöhn PC; Brandner S; Wadsworth JD; Collinge J; Tabrizi SJ
    J Biol Chem; 2005 Nov; 280(46):38851-61. PubMed ID: 16157591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form.
    Imamura M; Kato N; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T
    Microbiol Immunol; 2011 Sep; 55(9):633-40. PubMed ID: 21645053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.